A retrospective study to evaluate the effect of Brentuximab vedotin followed by allogeneic stem cell transplantation in subjects with relapsed or refractory Hodgkin's lymphoma.
Phase of Trial: Phase IV
Latest Information Update: 27 Nov 2015
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 27 Nov 2015 New trial record